Linker Information
General Information of This Linker
Linker ID |
LIN0EUGTC
|
|||||
---|---|---|---|---|---|---|
Linker Name |
Mal-Ile-Val
|
|||||
Linker Type |
Cathepsin-cleavable linker
|
|||||
Antibody-Linker Relation |
Cleavable
|
|||||
Structure | ||||||
Formula |
C20H33N5O5
|
|||||
Isosmiles |
CCC(C)C(NC(=O)C(N)C(C)C)C(=O)NCCNC(=O)CCN1C(=O)C=CC1=O
|
|||||
InChI |
InChI=1S/C20H33N5O5/c1-5-13(4)18(24-19(29)17(21)12(2)3)20(30)23-10-9-22-14(26)8-11-25-15(27)6-7-16(25)28/h6-7,12-13,17-18H,5,8-11,21H2,1-4H3,(H,22,26)(H,23,30)(H,24,29)
|
|||||
InChIKey |
ONGKJQVWBCDRPZ-UHFFFAOYSA-N
|
|||||
Pharmaceutical Properties |
Molecule Weight
|
423.514
|
Polar area
|
150.7
|
||
Complexity
|
30
|
xlogp Value
|
-0.9519
|
|||
Heavy Count
|
30
|
Rot Bonds
|
12
|
|||
Hbond acc
|
6
|
Hbond Donor
|
4
|
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
1F6-Ile-Val-AF [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
3.00 ng/mL
|
Positive CD70 expression (CD70+++/++) | ||
Method Description |
IC50 values are the mean and SD of 21 independent experimental titrations, each performed at least in duplicate.
|
||||
In Vitro Model | Renal cell carcinoma | 786-O cells | CVCL_1051 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
3.00 ng/mL
|
Positive CD70 expression (CD70+++/++) | ||
Method Description |
IC50 values are the mean and SD of 21 independent experimental titrations, each performed at least in duplicate.
|
||||
In Vitro Model | Hodgkin lymphoma | L-428 cells | CVCL_1361 | ||
Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
4.00 ng/mL
|
Positive CD70 expression (CD70+++/++) | ||
Method Description |
IC50 values are the mean and SD of 21 independent experimental titrations, each performed at least in duplicate.
|
||||
In Vitro Model | Clear cell renal cell carcinoma | Caki-1 cells | CVCL_0234 |
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.